These measures come against the backdrop of the COVID-19 pandemic, highlighting the urgent need for accurate public health communication. Critics posit these actions threaten the control necessary for addressing key health concerns across diverse populations. For example, Carl Schmid, Executive Director of the HIV+ Hepatitis Policy Institute, questioned how researchers and practitioners could effectively manage issues such as HIV and sexually transmitted diseases without language inclusive of all gender identities.
Federal health agencies purge LGBTQ+ data under Trump
“This is clearly aimed at erasing whole populations from federal policy and guidance, and it’s troubling for public health,” commented Carl Schmid, executive director of the HIV Hepatitis Policy Institute. “We can’t just erase or ignore certain populations when it actually affects their health outcomes.” The sentiment expresses concern over the undermining of important public health data.
CDC withdraws research papers due to Trump’s new gender policy directive
The US Center for Disease Control has ordered the withdrawal of all scientific papers for review in accordance with Trump’s decree to recognize only two articles. Experts and editors of scientific journals criticize this decision as unconstitutional.
The HIV Epidemic in Trump’s America
“You can’t take away healthcare from people living with HIV,” Schmid said in the Managed Healthcare Executive interview. “It is a lifetime requirement, and unfortunately, we don’t have the private insurance, adequate private insurance, adequate Medicaid programs to ensure that people have that care, treatment, and the support services, the case management to make sure people stay adherent to their medications.”
‘Chaos and fear’ at CDC amid order to retract journal articles to purge ‘forbidden terms’
“We can’t just erase or ignore certain populations when it comes to preventing, treating, or researching infectious diseases such as HIV. I certainly hope this is not the intent of these orders,” Carl Schmid, the executive director of the HIV+Hepatitis Policy Institute, told Reuters.